Generali Investments Towarzystwo Funduszy Inwestycyjnych Grows Position in The Cigna Group (NYSE:CI)

Generali Investments Towarzystwo Funduszy Inwestycyjnych lifted its stake in shares of The Cigna Group (NYSE:CI) by 30.2% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 2,800 shares of the health services provider’s stock after buying an additional 650 shares during the quarter. Generali Investments Towarzystwo Funduszy Inwestycyjnych’s holdings in The Cigna Group were worth $773,000 as of its most recent filing with the SEC.

Other hedge funds have also modified their holdings of the company. Adero Partners LLC boosted its stake in The Cigna Group by 4.5% during the 3rd quarter. Adero Partners LLC now owns 788 shares of the health services provider’s stock valued at $273,000 after purchasing an additional 34 shares during the period. CreativeOne Wealth LLC boosted its stake in The Cigna Group by 3.0% during the 3rd quarter. CreativeOne Wealth LLC now owns 1,219 shares of the health services provider’s stock valued at $422,000 after purchasing an additional 35 shares during the period. Hudson Edge Investment Partners Inc. boosted its stake in The Cigna Group by 1.9% during the 4th quarter. Hudson Edge Investment Partners Inc. now owns 1,883 shares of the health services provider’s stock valued at $520,000 after purchasing an additional 36 shares during the period. Smithfield Trust Co boosted its stake in The Cigna Group by 3.6% during the 3rd quarter. Smithfield Trust Co now owns 1,080 shares of the health services provider’s stock valued at $373,000 after purchasing an additional 38 shares during the period. Finally, Griffin Asset Management Inc. boosted its stake in The Cigna Group by 0.6% during the 4th quarter. Griffin Asset Management Inc. now owns 6,770 shares of the health services provider’s stock valued at $1,869,000 after purchasing an additional 39 shares during the period. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

The Cigna Group Stock Down 0.6 %

NYSE CI opened at $303.39 on Friday. The stock has a fifty day moving average of $288.90 and a 200-day moving average of $318.87. The stock has a market capitalization of $84.39 billion, a P/E ratio of 24.79, a price-to-earnings-growth ratio of 0.98 and a beta of 0.54. The Cigna Group has a 52 week low of $262.03 and a 52 week high of $370.83. The company has a debt-to-equity ratio of 0.70, a quick ratio of 0.72 and a current ratio of 0.66.

The Cigna Group (NYSE:CI) last released its earnings results on Thursday, January 30th. The health services provider reported $6.64 EPS for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same period last year, the firm earned $6.79 earnings per share. On average, equities research analysts forecast that The Cigna Group will post 29.77 EPS for the current year.

The Cigna Group Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, March 20th. Investors of record on Wednesday, March 5th will be paid a dividend of $1.51 per share. The ex-dividend date is Wednesday, March 5th. This is a boost from The Cigna Group’s previous quarterly dividend of $1.40. This represents a $6.04 dividend on an annualized basis and a dividend yield of 1.99%. The Cigna Group’s payout ratio is 49.35%.

Wall Street Analyst Weigh In

CI has been the subject of several recent analyst reports. Cantor Fitzgerald decreased their target price on The Cigna Group from $400.00 to $350.00 and set an “overweight” rating for the company in a research note on Friday, January 31st. Barclays reduced their price objective on The Cigna Group from $420.00 to $339.00 and set an “overweight” rating for the company in a research report on Friday, January 31st. StockNews.com upgraded The Cigna Group from a “hold” rating to a “buy” rating in a research report on Wednesday, February 19th. Wells Fargo & Company cut their target price on The Cigna Group from $370.00 to $341.00 and set an “equal weight” rating for the company in a research report on Tuesday, February 4th. Finally, Sanford C. Bernstein downgraded The Cigna Group from an “outperform” rating to a “market perform” rating and set a $323.00 target price for the company. in a research report on Thursday, February 6th. Two investment analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus price target of $372.31.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.